The Synergistic Effect of Zuogui Pill and Eldecalcitol on Improving Bone Mass and Osteogenesis in Type 2 Diabetic Osteoporosis

The Synergistic Effect of Zuogui Pill and Eldecalcitol on Improving Bone Mass and Osteogenesis in Type 2 Diabetic Osteoporosis

<i>Background and Objectives:</i> The incidence of diabetic osteoporosis, an important complication of diabetes mellitus, is increasing gradually. This study investigated the combined effect of the Zuogui pill (ZGP) and eldecalcitol (ED-71), a novel vitamin D analog, on type 2 diabetic o...

Full description

Bibliographic Details
Main Authors:	Tuo Shi, Ting Liu, Yuying Kou, Xing Rong, Lingxiao Meng, Yajun Cui, Ruihan Gao, Sumin Hu, Minqi Li
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Medicina
Subjects:	Zuogui pill eldecalcitol type 2 diabetic osteoporosis osteoblast PI3K–AKT signaling pathway
Online Access:	https://www.mdpi.com/1648-9144/59/8/1414

Similar Items

Fourier transform infrared spectroscopy analysis of the active components in serum of rats treated with Zuogui Pill
by: Yingli Wang, et al.
Published: (2015-10-01)

Exploring the mechanisms under Zuogui Pill’s treatment of ischemic stroke through network pharmacology and in vitro experimental verification
by: Li Li, et al.
Published: (2023-06-01)

Eldecalcitol prevented OVX-induced osteoporosis through inhibiting BMSCs senescence by regulating the SIRT1-Nrf2 signal
by: Yuying Kou, et al.
Published: (2023-03-01)

Inhibition of vitamin D analog eldecalcitol on hepatoma in vitro and in vivo
by: Ye Limin, et al.
Published: (2020-07-01)

Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials
by: Xu Z, et al.
Published: (2016-01-01)

Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
by: Mizue Tanaka, et al.
Published: (2017-03-01)

Hypercalcemia and acute kidney injury induced by eldecalcitol in patients with osteoporosis: a case series of 32 patients at a single facility
by: Seishi Aihara, et al.
Published: (2019-01-01)

Two-year effectiveness of zoledronic acid with or without eldecalcitol in Japanese patients with osteoporosis: A randomized prospective study
by: Takeshi Mochizuki, et al.
Published: (2022-06-01)

Exendin-4 and eldecalcitol synergistically promote osteogenic differentiation of bone marrow mesenchymal stem cells through M2 macrophages polarization via PI3K/AKT pathway
by: Yupu Lu, et al.
Published: (2022-03-01)

Eldecalcitol prevents muscle loss by suppressing PI3K/AKT/FOXOs pathway in orchiectomized mice
by: Haichao Zhang, et al.
Published: (2022-10-01)

An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Zuogui Jiangtang Shuxin Formula in Diabetic Cardiomyopathy
by: Huang Y, et al.
Published: (2023-01-01)

Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
by: Hongyan Liu, et al.
Published: (2022-04-01)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
by: Zaoqian Zheng, et al.
Published: (2020-09-01)

Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice
by: Bingbing Zhu, et al.
Published: (2022-11-01)

Eldecalcitol effectively prevents alveolar bone loss by partially improving Th17/Treg cell balance in diabetes-associated periodontitis
by: Ruihan Gao, et al.
Published: (2023-02-01)

Eldecalcitol prevents muscle loss and osteoporosis in disuse muscle atrophy via NF-κB signaling in mice
by: Haichao Zhang, et al.
Published: (2023-12-01)

Effects of risedronate, alendronate, and minodronate alone or in combination with eldecalcitol on bone mineral density, quality, and strength in ovariectomized rats
by: Tetsuo Yano, et al.
Published: (2021-06-01)

Zuogui Jiangtang Shuxin formula Ameliorates diabetic cardiomyopathy mice via modulating gut-heart axis
by: Ya-lan Huang, et al.
Published: (2023-02-01)

ED-71 Prevents Glucocorticoid-Induced Osteoporosis by Regulating Osteoblast Differentiation via Notch and Wnt/β-Catenin Pathways
by: Rong X, et al.
Published: (2022-11-01)

Protocol for a randomized study of the efficacy of ibandronic acid plus eldecalcitol in patients with gastric cancer after gastrectomy: A comparative study of different routes of administration of ibandronic acid [version 2; peer review: 2 approved]
by: Hideki Murakami, et al.
Published: (2023-05-01)

Protective effects of Zuogui Jiangtang Jieyu Formula on hippocampal neurons in rats of diabetes complicated with depression via the TRP/KYN metabolic pathway
by: Ling Jia, et al.
Published: (2022-06-01)

Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/β-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats
by: Xiaoya Li, et al.
Published: (2020-03-01)

Zuogui-Jiangtang-Qinggan-Fang alleviates high-fat diet-induced type 2 diabetes mellitus with non-alcoholic fatty liver disease by modulating gut microbiome-metabolites-short chain fatty acid composition
by: Junju Zou, et al.
Published: (2023-01-01)

ANALYSIS OF AN ALTERNATIVE TECHNOLOGY FOR PREPARING AND APPLYING PILLS IN WELL DRILLING
by: Alexey S. Korolev, et al.
Published: (2023-01-01)

Pills, Pills, and More Pills: A Pill Box Exercise to Teach Barriers to Medication Adherence and Solutions
by: Kathryn Denson, et al.
Published: (2015-11-01)

Qing`e Pill Inhibits Osteoblast Ferroptosis via ATM Serine/Threonine Kinase (ATM) and the PI3K/AKT Pathway in Primary Osteoporosis
by: Jian Hao, et al.
Published: (2022-07-01)

Erzhi Pill® Protected Experimental Liver Injury Against Apoptosis via the PI3K/Akt/Raptor/Rictor Pathway
by: Hai-Mei Zhao, et al.
Published: (2018-03-01)

Gel Pills for Downhole Pressure Control during Oil and Gas Well Drilling
by: Mahmoud Khalifeh, et al.
Published: (2020-11-01)

Eldecalcitol for the treatment of osteoporosis
by: Noguchi Y, et al.
Published: (2013-09-01)

Self-Tracking Pills
by: Mike Reaves
Published: (2015-11-01)

The pain of pills: The lived experiences of cured tuberculosis patients
by: Janmejaya Samal
Published: (2022-01-01)

MONOPHASIC AND THREEPHASIC ORAL CONTRACEPTIVE PILLS, A RANDOMIZED CLINICAL TRIAL ON THEIR SIDE EFFECTS
by: O. Zare, et al.
Published: (2004-04-01)

Pill Esophagitis: Clinical and Endoscopic Profile
by: Vikas Pemmada, et al.
Published: (2023-12-01)

Effect of Sishen Pill on Memory T Cells From Experimental Colitis Induced by Dextran Sulfate Sodium
by: Wei Ge, et al.
Published: (2020-07-01)

Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson’s disease
by: Dingyi Yu, et al.
Published: (2021-04-01)

The French pill scare and the reshaping of social inequalities in access to medical contraceptives
by: Mireille Le Guen, et al.
Published: (2020-08-01)

Predicting and Exploring the Mechanisms of Erzhi Pill in Prevention and Treatment of Osteoporosis Based on Network Pharmacology and Zebrafish Experiments
by: Zhong Z, et al.
Published: (2021-02-01)

Therapeutic Treatments for Osteoporosis—Which Combination of Pills Is the Best among the Bad?
by: Christian Horst Tonk, et al.
Published: (2022-01-01)

Pilling Resistance of Knitted Fabrics
by: Gita BUSILIENĖ, et al.
Published: (2011-09-01)

Pill Properties that Cause Dysphagia and Treatment Failure
by: Jeremy Fields, MD, et al.
Published: (2015-12-01)